312164
Spatial estimation of incidence rates (IR) using individual-level nation-wide population data: Acute myocardial infarction (AMI) in Denmark 2005-11
Objective To estimate the geographical distribution of incidence rate of AMI. To compare methods for estimating IR.
Methods Data were obtained from nation-wide registers. Three methods were used and compared. Initially, aggregated data at municipality level using hierarchical Bayesian analysis was used. Secondly, an iterative spatial generalized linear model (isGLM) was used to estimate IR accounting for the spatial distribution by modelling residuals using semivariogram models. Finally, a generalized linear model accounting for the IR in a 3km neighborhood (smoothGLM) was used.
Results The study population consisted of 3,501,621 residents (≥30 years) of which 74,037 (2.1%) experienced an incident AMI. IR was 318 per 100.000 person-years. The isGLM converged after 3 iterations. The isGLM and the smoothGLM resulted in very detailed IR maps identifying variation that were not seen using aggregated data.
Conclusions Spatial analysis of individual-level geocoded population data results in less smoothed maps of IR. Although methods are computer intensive, estimation is possible. Knowledge of the geographical distribution of AMI may contribute to more appropriate allocation of treatment resources.
Learning Areas:
Biostatistics, economicsChronic disease management and prevention
Epidemiology
Public health or related research
Learning Objectives:
Analyze geographical distribution of incidence rate of acute myocardial infarction in Denmark.
Compare methods for estimating the geographical distribution of incidence rates using individual-level geocoded data.
Keyword(s): Statistics, Heart Disease
Qualified on the content I am responsible for because: I am professor in register-based research and statistics. I am a statistician working with spatial epidemiology and statistics, health geographics. I have being working with this topic for more than 15 years
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.